Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

Publication date: July 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 7Author(s): David Z I Cherney, Claire C J Dekkers, Sean J Barbour, Daniel Cattran, Abdul Halim Abdul Gafor, Peter J Greasley, Gozewijn D Laverman, Soo Kun Lim, Gian Luca Di Tanna, Heather N Reich, Marc G Vervloet, Muh Geot Wong, Ron T Gansevoort, Hiddo J L Heerspink, DIAMOND investigators
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research